Sep 7, 2021

Influence of sarcopenia, clinical data, and 2-[¹⁸F] FDG PET/CT in outcome prediction of patients with early-stage adenocarcinoma esophageal cancer

European journal of nuclear medicine and molecular imaging

Reut Anconina, Claudia Ortega, Ur Metser, Zhihui Amy Liu, Chihiro Suzuki, Micheal McInnis, Gail E Darling, Rebecca Wong, Kirsty Taylor, Jonathan Yeung, Eric X Chen, Carol J Swallow, Jaspreet Bajwa, Raymond W Jang, Elena Elimova, Patrick Veit-Haibach

CONCLUSION: Combining the patients' imaging-derived sarcopenic status with standard clinical data, but not metabolic parameters, offered an overall improved prognostic value concerning OS and RFS.

Read Article

Influence of sarcopenia, clinical data, and 2-[18F] FDG PET/CT in outcome prediction of patients with early-stage adenocarcinoma esophageal cancer

Share This

Influence of sarcopenia, clinical data, and 2-[¹⁸F] FDG PET/CT in outcome prediction of patients with early-stage adenocarcinoma esophageal cancer